A highly specific and sensitive radioimmunoassay for circulating human
guanylin (guanylin-22-115) has been developed. Antibodies were raised
against the amino-terminus (positions 4-16) of the peptide. Western b
lot analysis confirmed that the antibody selected for radioimmunoassay
recognizes circulating high molecular weight (10.3 kDa) guanylin. Ext
raction and purification of guanylin from blood hemofiltrate and from
blood plasma showed that circulating guanylin is detectable in corresp
onding amounts by the radioimmunoassay and by a specific bioassay. In
30 healthy subjects, the mean plasma concentration of immunoreactive (
IR) guanylin was 42 +/- 3 fmol/ml. In 22 patients with chronic renal i
nsufficiency, the concentrations of IR-guanylin were significantly enh
anced (1,074 +/- 24 fmol/ml), indicating that kidneys metabolize and/o
r eliminate the circulating hormone.